Literature DB >> 1278093

The mechanism of action of the thioureylene antithyroid drugs.

A Taurog.   

Abstract

A model incubation system containing purified thyroid peroxidase (TPO) was used to study the mechanism of action of the thioureylene anti-thyroid drugs--propylthiouracil (PTU), methylmercapto imidazole (MMI) and carbimazole. Two general types of experiments were performed: a) measurement of the inhibitory effects of the drugs on TPO-catalyzed iodination and on TPO-catalyzed oxidation of guaiacol, and b) studies of the metabolism of PTU and MMI by the TPO model system. The major observations can be summarized as follows: 1) The thioureylene drugs are potent inhibitors of TPO-catalyzed iodination of protein and tyrosine. Their potency increases greatly as the concentration of I- decreases. 2) The thioureylene drugs are also potent inhibitors of TPO-catalyzed oxidation of guaiacol, a reaction that does not involve iodide. 3) MMI and PTU are readily oxidized in the model incubation system when iodide is present but not in the absence of iodide. The rate of oxidation increased as the iodide concentration was increased from 10 to 100 muM. 4) Oxidation of PTU and MMI by the model incubation system is inhibited by relatively slight increases in the concentration of PTU and MMI. These drugs are capable of inhibiting their own and each other's metabolism. 5) Inhibition of iodination is competitively antagonized by iodide at low drug concentrations, but not at higher drug concentrations. 6) Inhibition of iodination by MMI and PTU may be either reversible (low ratio of drug to iodide), or irreversible (higher ratio of drug to iodide). In reversible inhibition the iodination is inhibited for a period which may be as brief as 2 min or as long as 20 min, but thereafter, iodination begins, and there is escape from inhibition. During the lag-period there is extensive metabolism of the drug. In the case of irreversible inhibition of iodination is inhibited completely or almost completely for 60 min, and drug oxidation during this period is relatively low. 7) Irreversible inhibition may be transformed into reversible inhibition by increasing the concentration of TPO or the concentration of iodide. However, increasing the concentration of H2O2 or of tyrosine does not overcome irreversible inhibition. On the basis of these findings and of current views concerning the mechanism of enzymatic iodination, a scheme is proposed for the mechanism of inhibition by thioureylene drugs of TPO-catalyzed iodination of protein and tyrosine.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1278093     DOI: 10.1210/endo-98-4-1031

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  26 in total

1.  Assessment of synergistic thyroid disrupting effects of a mixture of EDCs in ovariectomized rats using factorial analysis and dose addition.

Authors:  Hao Chen; Zhaoping Liu; Xiaopeng Zhang; Xudong Jia; Qian Li; Qing Su; Wei Wang
Journal:  Toxicol Res (Camb)       Date:  2016-09-19       Impact factor: 3.524

Review 2.  Clinical features and management of overdosage with thyroid drugs.

Authors:  T H Lin; R T Kirkland; J L Kirkland
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Jul-Aug

3.  Iodothyronine metabolism in rat liver homogenates.

Authors:  M M Kaplan; R D Utiger
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

4.  Therapeutic exploration of betulinic acid in chemically induced hypothyroidism.

Authors:  Muhammad Afzal; Imran Kazmi; Susmita Semwal; Fahad A Al-Abbasi; Firoz Anwar
Journal:  Mol Cell Biochem       Date:  2013-10-05       Impact factor: 3.396

5.  Irreversible inactivation of lactoperoxidase by mercaptomethylimidazole through generation of a thiyl radical: its use as a probe to study the active site.

Authors:  U Bandyopadhyay; D K Bhattacharyya; R Chatterjee; R K Banerjee
Journal:  Biochem J       Date:  1995-03-15       Impact factor: 3.857

6.  Thyroid peroxidase forms thionamide-sensitive homodimers: relevance for immunomodulation of thyroid autoimmunity.

Authors:  David O McDonald; Simon H S Pearce
Journal:  J Mol Med (Berl)       Date:  2009-08-08       Impact factor: 4.599

7.  The effect of propylthiouracil on glutathione S-transferase activity of rat spleen in vitro and in vivo.

Authors:  K Kariya; E Lee; T Matsue
Journal:  Experientia       Date:  1983-08-15

8.  Early kinetics of thyroid trap in normal human patients and in thyroid diseases.

Authors:  J P Bazin; P Fragu; R Di Paola; M Di Paola; M Tubiana
Journal:  Eur J Nucl Med       Date:  1981

9.  Correlation between antithyroid effect and serum concentrations of propylthiouracil in patients with hyperthyroidism.

Authors:  J P Kampmann; J E Mølholm Hansen
Journal:  Br J Clin Pharmacol       Date:  1981-11       Impact factor: 4.335

10.  Degranulation and appearance of vesicular inclusions in canine C cells after administration of antithyroid drug.

Authors:  Y Kameda
Journal:  Cell Tissue Res       Date:  1982       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.